China blacklists Illumina amid tensions with the US, threatening its market access, while US actions limit Chinese rival MGI; CEO Jacob Thaysen seeks resolution as stock falls.

Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported ...

President Donald Trump on Friday reinstated a tariff loophole for small-value packages from China that was eliminated as part ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Ministry of Commerce has put parent company PVH on its Unreliable Entity List for violation of market principles.

Some senior partners have been voicing these concerns since late last year, even before Donald Trump was re-elected with a ...